| Calvin Harvey Jr, RN | |
|
175 Gwinnett Dr, Lawrenceville, GA 30046-8444 | |
| (678) 209-2394 | |
| (678) 212-6343 |
| Full Name | Calvin Harvey Jr |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - Psychiatric/mental Health, Child & Adolescent |
| Location | 175 Gwinnett Dr, Lawrenceville, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033570817 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
| 163WP0807X | Registered Nurse - Psychiatric/mental Health, Child & Adolescent | RN232563 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Calvin Harvey Jr, RN 4305 Gavira Ct, Cumming, GA 30040-0456 Ph: () - | Calvin Harvey Jr, RN 175 Gwinnett Dr, Lawrenceville, GA 30046-8444 Ph: (678) 209-2394 |
News Archive
An enzyme makes the mouse heart prone to chronic cardiac insufficiency – if it is suppressed, the heart remains strong despite increased stress.
Two years after inventing a microfluidic chip believed to help detect a life-threatening blood infection, researchers in the Texas Tech University Department of Chemistry & Biochemistry and the Texas Tech University Health Sciences Center are finally seeing their product work successfully for human patients.
Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Valacyclovir Hydrochloride tablets, USP, in the 500 and 1000 mg strengths, the generic equivalent to GlaxoSmithKline, LLC's VALTREX tablets.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Pfizer Inc. announced today top-line results from the ORAL Standard and ORAL Step Phase 3 studies of tofacitinib, an investigational, novel, oral JAK inhibitor.
› Verified 5 days ago